Patents by Inventor Jeffery Fong

Jeffery Fong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11739382
    Abstract: Methods for the rapid detection of the presence or absence of Hepatitis B Virus (HBV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, competitive blocking oligonucleotides, and probes targeting HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA) and kits are provided that are designed for the detection of HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA).
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: August 29, 2023
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Jeffery Fong, Aaron T. Hamilton, Marintha Heil, Igor Kozlov, Ed Gustavo Marins, Elizabeth Marie Scott, Ling Wang
  • Publication number: 20220275465
    Abstract: Methods for the rapid detection of the presence or absence of Hepatitis B Virus (HBV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, competitive blocking oligonucleotides, and probes targeting HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA) and kits are provided that are designed for the detection of HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA).
    Type: Application
    Filed: January 28, 2022
    Publication date: September 1, 2022
    Inventors: Alan Blair, Jeffery Fong, Aaron T. Hamilton, Marintha Heil, Igor Kozlov, Ed Gustavo Marins, Elizabeth Marie Scott, Ling Wang
  • Patent number: 11155886
    Abstract: Methods for the rapid detection of the presence or absence of Zika virus in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting Zika virus and kits are provided that are designed for the detection of Zika virus.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: October 26, 2021
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Slav Dugenny, Ellen H Fiss, Jeffery Fong, Marintha Heil, Eugene Spier, Jingtao Sun
  • Publication number: 20210062259
    Abstract: Methods for the rapid detection of the presence or absence of Hepatitis B Virus (HBV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, competitive blocking oligonucleotides, and probes targeting HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA) and kits are provided that are designed for the detection of HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA).
    Type: Application
    Filed: February 24, 2020
    Publication date: March 4, 2021
    Inventors: Jeffery Fong, Aaron T. Hamilton, Marintha Heil, Igor Kozlov, Ed Gustavo Marins, Elizabeth Marie Scott, Ling Wang
  • Publication number: 20200232051
    Abstract: Methods for the rapid detection of the presence or absence of Zika virus in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting Zika virus and kits are provided that are designed for the detection of Zika virus.
    Type: Application
    Filed: April 6, 2020
    Publication date: July 23, 2020
    Inventors: Slav Dugenny, Ellen H Fiss, Jeffery Fong, Marintha Heil, Eugene Spier, Jingtao Sun
  • Patent number: 10655190
    Abstract: Methods for the rapid detection of the presence or absence of Zika virus in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting Zika virus and kits are provided that are designed for the detection of Zika virus.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: May 19, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Slav Dugenny, Ellen H. Fiss, Jeffery Fong, Marintha Heil, Eugene Spier, Jingtao Sun
  • Publication number: 20170260596
    Abstract: Methods for the rapid detection of the presence or absence of Zika virus in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting Zika virus arid kits are provided that are designed for the detection of Zika virus.
    Type: Application
    Filed: March 10, 2017
    Publication date: September 14, 2017
    Inventors: Slav Dugenny, Ellen H. Fiss, Jeffery Fong, Marintha Heil, Eugene Spier, Jingtao Sun